8.05
0.43 (5.64%)
| Penutupan Terdahulu | 7.62 |
| Buka | 7.65 |
| Jumlah Dagangan | 1,243,809 |
| Purata Dagangan (3B) | 1,014,416 |
| Modal Pasaran | 6,335,776,768 |
| Harga / Pendapatan (P/E TTM) | 32.20 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.14 |
| Harga / Jualan (P/S) | 0.670 |
| Harga / Buku (P/B) | 0.830 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | 2.31% |
| Margin Operasi (TTM) | 20.06% |
| EPS Cair (TTM) | 0.250 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 12.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -13.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 123.24% |
| Nisbah Semasa (MRQ) | 2.26 |
| Aliran Tunai Operasi (OCF TTM) | 527.03 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 430.27 M |
| Pulangan Atas Aset (ROA TTM) | 2.87% |
| Pulangan Atas Ekuiti (ROE TTM) | 2.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - General (US) | Menaik | Menaik |
| Drug Manufacturers - General (Global) | Menaik | Menaik | |
| Stok | Grifols, S.A. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -4.0 |
| Purata | -1.00 |
|
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - General |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Institusi | 56.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Permian Investment Partners, Lp | 30 Sep 2024 | 12,333,499 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Purata Hasil Dividen 5T | 1.37% |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 03 Jun 2021 | 21 May 2021 | 14 Jun 2021 | 0.456586 Tunai |
| 30 Oct 2020 | 16 Oct 2020 | 09 Nov 2020 | 0.201439 Tunai |
| 02 Dec 2019 | 31 Oct 2019 | 11 Dec 2019 | 0.221872 Tunai |
| 07 Jun 2019 | 29 May 2019 | 18 Jun 2019 | 0.175638 Tunai |
| 30 Nov 2018 | 07 Nov 2018 | 11 Dec 2018 | 0.22789 Tunai |
| 01 Jun 2018 | 25 May 2018 | 12 Jun 2018 | 0.250975 Tunai |
| 01 Dec 2017 | - | 12 Dec 2017 | 0.212979 Tunai |
| 30 May 2017 | - | 08 Jun 2017 | 0.163528 Tunai |
| 05 Dec 2016 | - | 14 Dec 2016 | 0.193644 Tunai |
| 02 Jun 2016 | - | 15 Jun 2016 | 0.162059 Tunai |
| 10 Dec 2015 | - | 17 Dec 2015 | 0.384765 Tunai |
| 08 Jun 2015 | - | 15 Jun 2015 | 0.341846 Tunai |
| 04 Dec 2014 | - | 12 Dec 2014 | 0.312792 Tunai |
| 05 Jun 2013 | 24 May 2013 | 13 Jun 2013 | 0.258668 Tunai |
| Papar semua | |||
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2021 | 0.457 | 1 | 4.07 |
| 2020 | 0.201 | 1 | 1.09 |
| 2019 | 0.398 | 2 | 1.71 |
| 2018 | 0.479 | 2 | 2.61 |
| 2017 | 0.377 | 2 | 1.64 |
| 2016 | 0.356 | 2 | 2.21 |
| 2015 | 0.727 | 2 | 4.49 |
| 2014 | 0.313 | 1 | 1.84 |
| 2013 | 0.259 | 1 | 1.43 |
| Papar semua | |||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |